Skip to content
10-Q

Quarterly Report

SQZ BIOTECHNOLOGIES COMPANY

0000950170-22-014804

← back to feed
Filed
Aug 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 28, 2022 29.25M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $105.56M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $143.51M
Current Liabilities Q2 2022 · Jun 30, 2022 $28.44M
Current Liabilities Q2 2022 · Dec 31, 2021 $33.22M
Total Liabilities Q2 2022 · Jun 30, 2022 $92.12M
Total Liabilities Q2 2022 · Dec 31, 2021 $102.18M
Current Assets Q2 2022 · Jun 30, 2022 $110.05M
Current Assets Q2 2022 · Dec 31, 2021 $150.64M
Total Assets Q2 2022 · Jun 30, 2022 $180.31M
Total Assets Q2 2022 · Dec 31, 2021 $226.15M
Shares Diluted Q2 2022 · Jun 30, 2021 27.92M sh
Shares Diluted Q2 2022 · Jun 30, 2021 27.1M sh
Capex Q2 2022 · Jun 30, 2021 $521K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$40.23M
Stockholders Equity Q2 2022 · Jun 30, 2021 $152.7M
Stockholders Equity Q2 2022 · Mar 31, 2021 $169.29M
Stockholders Equity Q2 2022 · Dec 31, 2020 $127.2M
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.68
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.27
Eps Basic Q2 2022 · Jun 30, 2021 −$0.68
Eps Basic Q2 2022 · Jun 30, 2021 −$1.27
Sga Expense Q2 2022 · Jun 30, 2021 $5.93M
Sga Expense Q2 2022 · Jun 30, 2021 $12.05M
Rd Expense Q2 2022 · Jun 30, 2021 $17.68M
Rd Expense Q2 2022 · Jun 30, 2021 $32.42M
Net Income Q2 2022 · Jun 30, 2021 −$19.07M
Net Income Q2 2022 · Jun 30, 2021 −$34.47M
Operating Income Q2 2022 · Jun 30, 2021 −$19.08M
Operating Income Q2 2022 · Jun 30, 2021 −$34.48M